Related Experiment Video
Updated: Feb 22, 2026
Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
Published on: January 30, 2020
Defibrillation for Ventricular Fibrillation: A Shocking Update
Graham Nichol1, Michael R Sayre2, Federico Guerra3
1University of Washington-Harborview Center for Prehospital Emergency Care, University of Washington, Seattle, Washington.
Insights
Sudden cardiac death (SCD) is often caused by ventricular fibrillation. Defibrillation, using devices like automated external defibrillators (AEDs), is a key treatment to restore normal heart rhythm and improve survival rates.
Area of Science:
- Cardiology
- Emergency Medicine
- Medical Devices
Background:
- Sudden cardiac arrest (SCA) involves cessation of cardiac activity, leading to loss of consciousness and circulation.
- Sudden cardiac death (SCD) is frequently linked to underlying coronary artery disease.
- SCA is potentially reversible with interventions like cardiopulmonary resuscitation and defibrillation.
Purpose of the Study:
- To review the current state of defibrillation in treating sudden cardiac death (SCD).
- To discuss the evolution, technology, and accessibility of automated external defibrillators (AEDs).
- To explore strategies for improving survival rates and the role of implantable cardioverter-defibrillators (ICDs) and wearable cardioverter-defibrillators (WCDs).
Main Methods:
- Literature review of defibrillation techniques and devices for sudden cardiac death (SCD).
- Analysis of historical development and technical aspects of automated external defibrillators (AEDs).
- Examination of strategies to enhance AED accessibility and patient survival.
Main Results:
- Sudden cardiac death (SCD) is primarily addressed by defibrillation for shockable rhythms like ventricular fibrillation.
- Modern automated external defibrillators (AEDs) have evolved significantly in technology and usability.
- Improved AED access and timely intervention are critical for increasing survival rates from sudden cardiac arrest.
Conclusions:
- Defibrillation remains a cornerstone therapy for sudden cardiac death (SCD) caused by ventricular fibrillation.
- The effective use of automated external defibrillators (AEDs), implantable cardioverter-defibrillators (ICDs), and wearable cardioverter-defibrillators (WCDs) is crucial.
- Continued advancements in defibrillation technology and accessibility strategies are vital for improving outcomes in sudden cardiac arrest.
Abstract:
Cardiac arrest is defined as the termination of cardiac activity associated with loss of consciousness, of spontaneous breathing, and of circulation. Sudden cardiac arrest and sudden cardiac death (SCD) are terms often used interchangeably. Most patients with out-of-hospital cardiac arrest have shown coronary artery disease or symptoms during the hour before the event. Cardiac arrest is potentially reversible by cardiopulmonary resuscitation, defibrillation, cardioversion, cardiac pacing, or treatments targeted at the underlying disease (e.g., acute coronary occlusion). We restrict SCD hereafter to cardiac arrest due to ventricular fibrillation, including rhythms shockable by an automatic external defibrillator (AED), implantable cardioverter-defibrillator (ICD), or wearable cardioverter-defibrillator (WCD). We summarize the state of the art related to defibrillation in treating SCD, including a brief history of the evolution of defibrillation, technical characteristics of modern AEDs, strategies to improve AED access and increase survival, ancillary treatments, and use of ICDs or WCDs.
Related Concept Videos
01:29Dysrhythmias III: Characteristics of Dysrhythmias
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
01:23Cardiopulmonary Resuscitation III: AED Use
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
01:29Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
01:25Dysrhythmias VI: Management of Dysrhythmias